Publication:
Impaired inhibitory GABAergic synaptic transmission and transcription studied in single neurons by Patch-seq in Huntington's disease

dc.contributor.coauthorParaskevopoulou, Foteini
dc.contributor.coauthorParvizi, Poorya
dc.contributor.coauthorSenger, Gokce
dc.contributor.coauthorRosenmund, Christian
dc.contributor.coauthorYildirim, Ferah
dc.contributor.departmentDepartment of Chemical and Biological Engineering
dc.contributor.departmentDepartment of Chemical and Biological Engineering
dc.contributor.kuauthorTunçbağ, Nurcan
dc.contributor.kuprofileFaculty Member
dc.contributor.schoolcollegeinstituteCollege of Engineering
dc.contributor.yokid245513
dc.date.accessioned2024-11-09T23:11:10Z
dc.date.issued2021
dc.description.abstractTranscriptional dysregulation in Huntington's disease (HD) causes functional deficit s in striatal neurons. Here, we performed Patch-sequencing (Patch-seq) in an in vitro HD model to investigate the effects of mutant Huntingtin (Htt ) on synaptic transmission and gene transcription in single striatal neurons. We found that expression of mutant Htt decreased the synaptic output of striatal neurons in a cell autonomous fashion and identified a number of genes whose dysregulation was correlated with physiological deficiencies in mutant Htt neurons. In support of a pivotal role for epigenetic mechanisms in HD pathophysiology, we found that inhibiting histone deacetylase 1/3 activities rectified several functional and morphological deficit s and alleviated the aberrant transcriptional profiles in mutant Htt neurons. With this study, we demonstrate that Patch-seq technology can be applied both to better understand molecular mechanisms underlying a complex neurological disease at the single-cell level and to provide a platform for screening for therapeutics for the disease.
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue19
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipThis work was funded by the NeuroCure Cluster of Excellence Exc 257 funding (F.Y. and C.R.) and by German Research Council Grants SFB665/B11 and RO1296/12-1 (C.R.). We thank Christoph Harms for help with initial generation of mutant and wild-type Htt-expressing lentiviruses and Bettina Brokowski, Rike Dannenberg, Berit Sohl-Kielczynski, Heike Lerch, Belgin Cansin Peksen, Miriam Petzold, and Katja Potschke for technical assistance. We acknowledge the Scientific Genomics Platforms at the Max Delbruck Center for Molecular Medicine Berlin and at the Berlin Institute of Health for sequencing RNA-seq libraries. We also thank Melissa A. Herman and David E. Housman for critically reading and insightful comments on the manuscript.
dc.description.volume118
dc.identifier.doi10.1073/pnas.2020293118
dc.identifier.eissn1091-6490
dc.identifier.issn0027-8424
dc.identifier.quartileQ1
dc.identifier.scopus2-s2.0-85105445344
dc.identifier.urihttp://dx.doi.org/10.1073/pnas.2020293118
dc.identifier.urihttps://hdl.handle.net/20.500.14288/9587
dc.identifier.wos651329300003
dc.keywordsHuntington's disease
dc.keywordsSingle-cell RNA sequencing
dc.keywordsPatch-seq
dc.keywordsSynaptic function
dc.keywordsStriatum
dc.languageEnglish
dc.publisherNational Academy of Sciences
dc.sourceProceedings of the National Academy of Sciences of the United States of America
dc.subjectMultidisciplinary sciences
dc.titleImpaired inhibitory GABAergic synaptic transmission and transcription studied in single neurons by Patch-seq in Huntington's disease
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.authorid0000-0002-0389-9459
local.contributor.kuauthorTunçbağ, Nurcan
relation.isOrgUnitOfPublicationc747a256-6e0c-4969-b1bf-3b9f2f674289
relation.isOrgUnitOfPublication.latestForDiscoveryc747a256-6e0c-4969-b1bf-3b9f2f674289

Files